
Alexion Pharmaceuticals, Inc. ALXN
Alexion Pharmaceuticals, Inc. DSO Ratio 2011-2026 | ALXN
Annual DSO Ratio Alexion Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 84.7 | 90.9 | 81.5 | 74.7 | 76.9 | 74.7 | 70.7 | 99.2 | 95.1 | 114 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 114 | 70.7 | 86.2 |
DSO Ratio of other stocks in the Biotechnology industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Adverum Biotechnologies
ADVM
|
222 | - | - | $ 86.2 M | ||
|
Acorda Therapeutics
ACOR
|
48.3 | - | -24.86 % | $ 820 K | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Akebia Therapeutics
AKBA
|
62.9 | $ 1.4 | -0.71 % | $ 360 M | ||
|
Aravive
ARAV
|
16.8 | - | -13.39 % | $ 1.45 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
28.1 | $ 2.92 | -0.34 % | $ 6.35 B | ||
|
Aytu BioScience
AYTU
|
150 | $ 2.55 | -0.78 % | $ 16 M | ||
|
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
70.9 | $ 20.37 | -2.4 % | $ 952 M | ||
|
Aquestive Therapeutics
AQST
|
103 | $ 4.08 | -2.16 % | $ 436 M | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Arcutis Biotherapeutics
ARQT
|
106 | $ 24.21 | -1.47 % | $ 3.08 B | ||
|
BeiGene, Ltd.
BGNE
|
52.6 | - | 0.49 % | $ 251 B | ||
|
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
Celldex Therapeutics
CLDX
|
321 | $ 32.24 | -4.1 % | $ 2.14 B | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.114 | - | - | $ 26.5 M | ||
|
CymaBay Therapeutics
CBAY
|
182 | - | - | $ 3.45 B | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Avid Bioservices
CDMO
|
45.6 | - | - | $ 789 M | ||
|
Cidara Therapeutics
CDTX
|
2.26 K | - | - | $ 1.41 B | ||
|
Immutep Limited
IMMP
|
351 | $ 0.31 | -2.52 % | $ 1.08 B | ||
|
Checkpoint Therapeutics
CKPT
|
6.83 | - | - | $ 169 M | ||
|
CureVac N.V.
CVAC
|
13.6 | - | - | $ 867 M | ||
|
Concert Pharmaceuticals
CNCE
|
147 | - | - | $ 401 M | ||
|
Celsion Corporation
CLSN
|
15.6 | - | -6.63 % | $ 13.9 M |